肿瘤巩固治疗临床研究现状  

The Progress of Clinical Cancer Consolidation Therapy

作　　者：舒荣文[1] 孔庆军[1] 许德兵[1] 李宝石[1] 潘士勇[1] 

机构地区：[1]南京军区南京总医院,江苏南京210024

出　　处：《现代生物医学进展》2014年第27期5380-5383,共4页Progress in Modern Biomedicine

摘　　要：随着医学水平的不断进步,巩固治疗已广泛应用于造血系统肿瘤及各种实体瘤的临床治疗,治疗方案为巩固化疗/维持化疗、巩固放疗、免疫调节剂和中药巩固治疗。虽然巩固治疗在肿瘤治疗的应用中起到了积极地效果,但临床治疗中仍在探索抗肿瘤疗效确切、安全性高、毒副作用小、提高患者机体免疫功能且治疗费用经济的巩固治疗药物和方案,从而有效延长患者生存期。本文就这些药物的应用和研究进展进行综述。With the development of medical standards, consolidation has been widely used in a variety of hematopoietic tumors and the clinical treatment of solid tumors, treatment options for the consolidation chemotherapy/ maintenance chemotherapy, consolidation radiotherapy, immunomodulators and consolidation therapy of traditional Chinese medicine. Although consolidation therapy applications in cancer therapy has played a positive effect, but treatment is still exploring the clinical anti-tumor efficacy, high safety, toxicity, and improve immune function in patients with treatment consolidation of the economic cost of treatment and programs to effectively prolong the survival period. In this paper, the application of these drugs and research are reviewed.

关 键 词：肿瘤 巩固治疗 药物 

分 类 号：R730.5[医药卫生—肿瘤]